Fig. 6
From: Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Tissue metabolites as biomarkers to differentiate between subtype A and subtype B. Box plots showing relative abundances for the 7 metabolite-panel to distinguish PC subtypes A and B in addition with data from subtype non-AB and benign prostate tissues. Data are expressed as means ± standard deviation and statistical significance was determined using the one-way ANOVA followed by post-hoc Benjamini-Hochberg (FDR, false discovery rate) test and a p-value < 0.05 was considered statistically significant. PC + GPC—peak for combined phosphocholine/glycerophosphocholine metabolites; Glx: combined signal of glutamate/glutamine